Canada markets open in 4 hours 59 minutes

Simcere Pharmaceutical Group Ltd (S2P.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.6750+0.0150 (+2.27%)
As of 08:10AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
6,607,805
6,607,805
6,324,082
4,999,718
4,508,720
-
Cost of Revenue
1,623,652
1,623,652
1,327,404
1,079,983
899,927
-
Gross Profit
4,984,153
4,984,153
4,996,678
3,919,735
3,608,793
-
Operating Expenses
Research Development
1,563,138
1,563,138
1,728,283
1,416,721
1,141,996
-
Selling General and Administrative
2,844,215
2,844,215
2,842,158
2,395,525
1,978,480
-
Total Operating Expenses
4,257,652
4,257,652
4,422,047
3,687,923
3,018,910
-
Operating Income or Loss
726,501
726,501
574,631
231,812
589,883
-
Interest Expense
34,568
34,568
34,408
70,848
133,729
-
Income Before Tax
740,038
740,038
886,254
1,401,797
805,088
-
Income Tax Expense
26,088
26,088
-40,478
-97,124
140,801
-
Income from Continuing Operations
713,950
713,950
926,732
1,498,921
664,287
-
Net Income
714,761
714,761
930,868
1,507,096
669,534
-
Net Income available to common shareholders
714,761
714,761
930,868
1,507,096
669,534
-
Basic EPS
1.21
-
0.36
0.58
0.26
0.39
Diluted EPS
1.20
-
0.36
0.58
0.26
0.39
Basic Average Shares
2,616,326
-
2,611,172
2,608,642
2,608,642
2,605,687
Diluted Average Shares
2,626,069
-
2,620,376
2,611,358
2,608,642
2,605,687